Health CanadaGeneral Alert
Forxiga, Invokana: Health Canada begins safety review of diabetes drugs known as...
Published: June 22, 2015Recall ID: 53694Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Forxiga, Invokana: Health Canada begins safety review of diabetes drugs known as SGLT2 inhibitors and risk of ketoacidosis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 53694 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/forxiga-invokana-health-canada-begins-safety-review-diabetes-drugs-known-sglt2 |
| Issue | Product safety |
| Title | Forxiga, Invokana: Health Canada begins safety review of diabetes drugs known as SGLT2 inhibitors and risk of ketoacidosis |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2015-06-22 |
| Organization | Communications and Public Affairs Branch |